/ / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners and coroners, forensic and clinical laboratory personnel, and all other related communities about new information surrounding the emergent synthetic opioid etodesnitazene.
Tags: Etodesnitazene New Drug Trends Opioid Crisis Safety Alert Trend ReportsN-Pyrrolidino Etonitazene has been identified in one case in May 2021. The geographical and demographical breakdown is below: Geographical...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report this week. Using data...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released an update on benzodiazepines this week. As of February...
The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
The NDEWS team has launched the Rapid Street Reporting (RSR) study, with the first weekend visit occurring November 12-14...
Purpose: The objective of this announcement is to notify public health and safety, clinicians, law enforcement, first responders, medical...
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
TX: Doctor Sentenced for $54M Medicare Fraud Scheme October 29, 2024
China-Based Chemical Manufacturing Companies and Employees Indicted for Alleged Fentanyl Manufacturing and Distribution October 24, 2024
Massachusetts mother and son sentenced to prison for role in DTO that allegedly distributed 10s of thousands of counterfeit pills containing fentanyl, meth October 13, 2024
National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913
Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy
